Although the COVID-19 pandemic hasn't been kind to most equities this year, some biotech and healthcare stocks have gotten a huge boost from this deadly respiratory illness. In particular, a select group of companies working on experimental COVID-19 vaccines and therapies have seen their share prices skyrocket in 2020.
Shares of biotechs Inovio Pharmaceuticals (NASDAQ: INO), Mesoblast (NASDAQ: MESO), and Moderna (NASDAQ: MRNA), for instance, have all gone parabolic in April. Can these three red-hot biotech stocks keep churning higher, or is it time to take profits? Let's break down the near-term outlook for each company to find out.
Image source: Getty Images.